Fidelity Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.2M | Sell |
|
|||||
|
2025
Q2 | $32M | Buy |
|
|||||
|
2025
Q1 | $10.6M | Sell |
|
|||||
|
2024
Q4 | $19.1M | Sell |
|
|||||
|
2024
Q3 | $28.4M | Sell |
|
|||||
|
2024
Q2 | $47.1M | Buy |
|
|||||
|
2024
Q1 | $32.1M | Sell |
|
|||||
|
2023
Q4 | $34.9M | Buy |
|
|||||
|
2023
Q3 | $2.48M | Buy |
|
|||||
|
2023
Q2 | $904K | Sell |
|
|||||
|
2023
Q1 | $3.3M | Sell |
|
|||||
|
2022
Q4 | $93.9M | Buy |
|
|||||
|
2022
Q3 | $36.4M | Buy |
|
|||||
|
2022
Q2 | $22.8M | Sell |
|
|||||
|
2022
Q1 | $22.5M | Sell |
|
|||||
|
2021
Q4 | $57.5M | Sell |
|
|||||
|
2021
Q3 | $332M | Sell |
|
|||||
|
2021
Q2 | $412M | Sell |
|
|||||
|
2021
Q1 | $691M | Sell |
|
|||||
|
2020
Q4 | $801M | Sell |
|
|||||
|
2020
Q3 | $837M | Buy |
|
|||||
|
2020
Q2 | $1.02B | Buy |
|
|||||
|
2020
Q1 | $630M | Sell |
|
|||||
|
2019
Q4 | $786M | Sell |
|
|||||
|
2019
Q3 | $778M | Sell |
|
|||||
|
2019
Q2 | $777M | Sell |
|
|||||
|
2019
Q1 | $920M | Sell |
|
|||||
|
2018
Q4 | $930M | Sell |
|
|||||
|
2018
Q3 | $1.66B | Buy |
|
|||||
|
2018
Q2 | $1.32B | Buy |
|
|||||
|
2018
Q1 | $1.11B | Buy |
|
|||||
|
2017
Q4 | $1.03B | Buy |
|
|||||
|
2017
Q3 | $811M | Buy |
|
|||||
|
2017
Q2 | $608M | Buy |
|
|||||
|
2017
Q1 | $521M | Sell |
|
|||||
|
2016
Q4 | $501M | Sell |
|
|||||
|
2016
Q3 | $658M | Buy |
|
|||||
|
2016
Q2 | $577M | Sell |
|
|||||
|
2016
Q1 | $513M | Buy |
|
|||||
|
2015
Q4 | $731M | Buy |
|
|||||
|
2015
Q3 | $513M | Buy |
|
|||||
|
2015
Q2 | $528M | Sell |
|
|||||
|
2015
Q1 | $472M | Buy |
|
|||||
|
2014
Q4 | $255M | Buy |
|
|||||
|
2014
Q3 | $178M | Buy |
|
|||||
|
2014
Q2 | $169M | Buy |
|
|||||
|
2014
Q1 | $182M | Buy |
|
|||||
|
2013
Q4 | $94.3M | Buy |
|
|||||
|
2013
Q3 | $114M | Buy |
|
|||||
|
2013
Q2 | $127M | Buy |
|